09 November 2023
09 November 2023
Technological integration and collaboration with patient associations have the potential to solve the public’s lack of awareness about clinical research.
A UK-based study investigating a different approach towards recruitment identified significantly more eligible interested patients.
The company has prioritised the development of ADI-270 in renal cell carcinoma while pausing the preclinical development of ADI-925.
No new safety signals linked to the treatment were reported in the trial establishing its favourable safety profile so far.
In the trial, a single intravitreal dose of AG-73305 was demonstrated to be safe and tolerable in DME patients.
The company plans to make available Clinical Data Studio and Health Record Connect in the first half of next year.
The published study shows that specific amyloid and tau protein biomarkers increase the accuracy of amyloid PET classification in pre-clinical Alzheimer's disease.
Merging industry-leading business intelligence & award-winning journalism, this is an unrivalled opportunity for engagement with B2B professionals across a network of 40+ leading media websites.
Steer your business strategy with key data and insights from our latest market research reports and company profiles. Not ready to buy? Start small by downloading a sample report first.
Give your business an edge with our leading industry insights.
